Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease [Research Articles]
This study aimed to examine the associations of TRL-C, RLP-C, and apoC-III with incident cardiovascular events (CVEs) in the setting of secondary prevention of CAD. Plasma TRL-C, RLP-C, and total apoC-III were directly measured. A total of 4,355 participants with angiographically confirmed CAD were followed up for the occurrence of CVEs. During a median follow-up period of 5.1 years (interquartile range: 3.9–6.4 years), 543 (12.5%) events occurred. Patients with incident CVEs had significantly higher levels of TRL-C, RLP-C, and apoC-III than those without events. Multivariable Cox analysis indicated that a log unit increase in TRL-C, RLP-C, and apoC-III increased the risk of CVEs by 49% (95% CI: 1.16–1.93), 21% (95% CI: 1.09–1.35), and 40% (95% CI: 1.11–1.77), respectively. High TRL-C, RLP-C, and apoC-III were also independent predictors of CVEs in individuals with LDL-C levels ≤1.8 mmol/l (n = 1,068). The addition of RLP-C level to a prediction model resulted in a significant increase in discrimination, and all three TRL biomarkers improved risk reclassification. Thus, TRL-C, RLP-C, and apoC-III levels were independently associated with incident CVEs in Chinese CAD patients undergoing statin therapy.
Source: The Journal of Lipid Research - Category: Lipidology Authors: Cao, Y.-X., Zhang, H.-W., Jin, J.-L., Liu, H.-H., Zhang, Y., Xu, R.-X., Gao, Y., Guo, Y.-L., Zhu, C.-G., Hua, Q., Li, Y.-F., Santos, R. D., Wu, N.-Q., Li, J.-J. Tags: Research Articles Source Type: research
More News: Angiography | Cardiology | Cardiovascular | China Health | Cholesterol | Heart | Lipidology | Statin Therapy | Study